Distribution of organic cation transporter 3, a corticosterone-sensitive monoamine transporter, in the rat brain

Journal of Comparative Neurology

Volumn 512, Issue 4, 2009, Pages 529-555

  Gasser, Paul J ^a   Orchinik, Miles ^b   Raju, Ilangovan ^a   Lowry, Christopher A ^c,d  

^a MARQUETTE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Dopamine; Extraneuronal monoamine transporter; Histamine; Norepinephrine; Serotonin; Stress

Indexed keywords

MONOAMINE; ORGANIC CATION TRANSPORTER 3; BIOGENIC AMINE; CORTICOSTERONE; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 3;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN VENTRICLE; CELLULAR DISTRIBUTION; CEREBELLUM; CONTROLLED STUDY; ENZYME SPECIFICITY; EPENDYMA CELL; FOREBRAIN; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; INFERIOR COLLICULUS; MALE; MESENCEPHALON; NEUROTRANSMISSION; NONHUMAN; OLFACTORY NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RHOMBENCEPHALON; SUBICULUM; SUPERIOR COLLICULUS; ANIMAL; BRAIN; CYTOLOGY; GENETICS; HISTOLOGY; METABOLISM; NERVE CELL; SPRAGUE DAWLEY RAT;

ANIMALS; BIOGENIC MONOAMINES; BRAIN; CORTICOSTERONE; MALE; NEURONS; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 59649089875     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.21921     Document Type: Article

References (72)

1. Alnouti Y, Petrick JS, Klaassen CD. 2006. Tissue distribution and ontogeny of organic cation transporters in mice. Drug Metab Dispos 34:477-482.
2. Amphoux A, Vialou V, Drescher E, Bruss M, La Cour CM, Rochat C, Millan MJ, Giros B, Bonisch H, Gautron S. 2006. Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology 50:941-952.
3. Aston-Jones G. 2004. Locus coeruleus, A5 and A7 noradrenergic cell groups. In: Paxinos G, editor. The rat nervous system. Amsterdam: Elsevier. p 259-294.
4. Bongarzone ER, Howard SG, Schonmann V, Campagnoni AT. 1998. Identification of the dopamine D3 receptor in oligodendrocyte precursors: potential role in regulating differentiation and myelin formation. J Neurosci 18:5344-5353.
5. Cohen RI, Almazan G. 1993. Norepinephrine-stimulated PI hydrolysis in oligodendrocytes is mediated by alpha 1A-adrenoceptors. Neuroreport 4:1115-1118.
6. Deutch AY, Cameron DS. 1992. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience 46:49-56.
7. Deutch AY, Goldstein M, Baldino F Jr, Roth RH. 1988. Telencephalic projections of the A8 dopamine cell group. Ann N Y Acad Sci 537:27-50.
8. Eisenhofer G. 2001. The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines. Pharmacol Ther 91:35-62.
9. Engel K, Zhou M, Wang J. 2004. Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem 279: 50042-50049.
10. Fallon JH, Moore RY. 1978. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol 180:545-580.
11. Fallon JH, Riley JN, Sipe JC, Moore RY. 1978. The islands of Calleja: organization and connections. J Comp Neurol 181:375-395.
12. Fallon JH, Loughlin SE, Ribak CE. 1983. The islands of Calleja complex of rat basal forebrain. III. Histochemical evidence for a striatopallidal system. J Comp Neurol 218:91-120.
13. Febvret A, Berger B, Gaspar P, Verney C. 1991. Further indication that distinct dopaminergic subsets project to the rat cerebral cortex: lack of colocalization with neurotensin in the superficial dopaminergic fields of the anterior cingulate, motor, retrosplenial and visual cortices. Brain Res 547:37-52.
14. Feng N, Mo B, Johnson PL, Orchinik M, Lowry CA, Renner KJ. 2005. Local inhibition of organic cation transporters increases extracellular serotonin in the medial hypothalamus. Brain Res 1063:69-76.
15. Fuxe K, Jacobsen KX, Hoistad M, Tinner B, Jansson A, Staines WA, Agnati LF. 2003. The dopamine D1 receptor-rich main and paracapsular intercalated nerve cell groups of the rat amygdala: relationship to the dopamine innervation. Neuroscience 119:733-746.
16. Gasser PJ, Lowry CA, Orchinik M. 2006. Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. J Neurosci 26:8758-8766.
17. Grundemann D, Schomig E. 2000. Gene structures of the human nonneuronal monoamine transporters EMT and OCT2. Hum Genet 106:627-635.
18. Grundemann D, Schechinger B, Rappold GA, Schomig E. 1998. Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nat Neurosci 1:349-351.
19. Grundemann D, Liebich G, Kiefer N, Koster S, Schomig E. 1999. Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol 56:1-10.
20. Haag C, Berkels R, Grundemann D, Lazar A, Taubert D, Schomig E. 2004. The localisation of the extraneuronal monoamine transporter (EMT) in rat brain. J Neurochem 88:291-297.
21. Hamlet MA, Rorie DK, Tyce GM. 1980. Effects of estradiol on release and disposition of norepinephrine from nerve endings. Am J Physiol 239: H450-H456.
22. Horvath G, Lieb T, Conner GE, Salathe M, Wanner A. 2001. Steroid sensitivity of norepinephrine uptake by human bronchial arterial and rabbit aortic smooth muscle cells. Am J Respir Cell Mol Biol 25:500-506.
23. Horvath G, Sutto Z, Torbati A, Conner GE, Salathe M, Wanner A. 2003. Norepinephrine transport by the extraneuronal monoamine transporter in human bronchial arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 285:829-837.
24. Inazu M, Takeda H, Matsumiya T. 2003. Expression and functional characterization of the extraneuronal monoamine transporter in normal human astrocytes. J Neurochem 84:43-52.
25. Iversen LL. 1965. The uptake of catecholamines at high perfusion concentrations in the rat isolated heart. A novel catecholamine uptake process. Br J Pharmacol Chemother 25:18-33.
26. Iversen LL. 1971. Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol 41:571-591.
27. Iversen LL, Salt PJ. 1970. Inhibition of catecholamine uptake-2 by steroids in the isolated rat heart. Br J Pharmacol 40:528-530.
28. Iversen LL, Jarrott B, Simmonds MA. 1971. Differences in the uptake, storage and metabolism of (b)- and (-)-noradrenaline. Br J Pharmacol 43:845-855.
29. Jacobs BL, Azmitia EC. 1992. Structure and function of the brain serotonin system. Physiol Rev 72:165-229.
30. Jayanthi LD, Ramamoorthy S. 2005. Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants. AAPS J 7:E728-E738.
31. Johnson SM, de la Lande I. 1978. Action of deoxycorticosterone acetate on the central artery of the rabbit ear. Blood Vessels 15:231-246.
32. Kalivas PW, Duffy P. 1995. Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res 675:325-328.
33. + channels by multiple neurotransmitter receptors in oligodendroglia. Eur J Neurosci 6:1756-1764.
34. Kitaichi K, Morishita Y, Doi Y, Ueyama J, Matsushima M, Zhao YL, Takagi K, Hasegawa T. 2003. Increased plasma concentration and brain penetration of methamphetamine in behaviorally sensitized rats. Eur J Pharmacol 464:39-48.
35. Kitaichi K, Fukuda M, Nakayama H, Aoyama N, Ito Y, Fujimoto Y, Takagi K, Takagi K, Hasegawa T. 2005. Behavioral changes following antisense oligonucleotide-induced reduction of organic cation transporter-3 in mice. Neurosci Lett 382:195-200.
36. Kristufek D, Rudorfer W, Pifl C, Huck S. 2002. Organic cation transporter mRNA and function in the rat superior cervical ganglion. J Physiol 543:117-134.
37. Kusuhara H, Sugiyama Y. 2004. Efflux transport systems for organic anions and cations at the blood-CSF barrier. Adv Drug Deliv Rev 56:1741-1763.
38. Lazar A, Walitza S, Jetter A, Gerlach M, Warnke A, Herpertz-Dahlmann B, Grundemann D, Grimberg G, Schulz E, Remschmidt H, Wewetzer C, Schomig E. 2007. Novel mutations of the extraneuronal monoamine transporter gene in children and adolescents with obsessive-compulsive disorder. Int J Neuropsychopharmacol 11:1-14.
39. Lightman SL, Iversen LL. 1969. The role of uptake2 in the extraneuronal metabolism of catecholamines in the isolated rat heart. Br J Pharmacol 37:638-649.
40. Lips KS, Volk C, Schmitt BM, Pfeil U, Arndt P, Miska D, Ermert L, Kummer W, Koepsell H. 2005. Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium. Am J Respir Cell Mol Biol 33:79-88.
41. Losada MEO. 1988. Corticosterone-induced acute changes on biogenic amines levels in some areas of the rat brain. Biogenic Amines 5:239-247.
42. Lowry CA, Burke KA, Renner KJ, Moore FL, Orchinik M. 2001. Rapid changes in monoamine levels following administration of corticotropin-releasing factor or corticosterone are localized in the dorsomedial hypothalamus. Horm Behav 39:195-205.
43. Lowry CA, Plant A, Shanks N, Ingram CD, Lightman SL. 2003. Anatomical and functional evidence for a stress-responsive, monoamine-accumulating area in the dorsomedial hypothalamus of adult rat brain. Horm Behav 43:254-262.
44. McLean JH, Shipley MT, Nickell WT, Aston-Jones G, Reyher CK. 1989. Chemoanatomical organization of the noradrenergic input from locus coeruleus to the olfactory bulb of the adult rat. J Comp Neurol 285: 339-349.
45. Michel MC, Rother A, Hiemke C, Ghraf R. 1987. Inhibition of synaptosomal high-affinity uptake of dopamine and serotonin by estrogen agonists and antagonists. Biochem Pharmacol 36:3175-3180.
46. Mikkelsen JD, Hay-Schmidt A, Larsen PJ. 1997. Central innervation of the rat ependyma and subcommissural organ with special reference to ascending serotoninergic projections from the raphe nuclei. J Comp Neurol 384:556-568.
47. Mittleman G, Blaha CD, Phillips AG. 1992. Pituitary-adrenal and dopaminergic modulation of schedule-induced polydipsia: behavioral and neurochemical evidence. Behav Neurosci 106:408-420.
48. Morrison JH, Molliver ME, Grzanna R, Coyle JT. 1979. Noradrenergic innervation patterns in three regions of medial cortex: an immunofluorescence characterization. Brain Res Bull 4:849-857.
49. Nemeroff CB, Owens MJ. 2004. Pharmacologic differences among the SSRIs: focus on monoamine transporters and the HPA axis. CNS Spectr 9:23-31.
50. Oades RD, Halliday GM. 1987. Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res 434:117-165.
51. Panula P, Pirvola U, Auvinen S, Airaksinen MS. 1989. Histamine-immunoreactive nerve fibers in the rat brain. Neuroscience 28:585-610.
52. Piazza PV, Rouge-Pont F, Deroche V, Maccari S, Simon H, Le MM. 1996. Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc Natl Acad Sci U S A 93:8716-8720.
53. Rahman Z, Ring RH, Young K, Platt B, Lin Q, Schechter LE, Rosenzweig-Lipson S, Beyer CE. 2008. Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxine. Brain Res 1203:68-78.
54. Reyes-Haro D, Garcia-Alcocer G, Miledi R, Garcia-Colunga J. 2003. Uptake of serotonin by adult rat corpus callosum is partially reduced by common antidepressants. J Neurosci Res 74:97-102.
55. Roozendaal B. 2000. 1999 Curt P. Richter award. Glucocorticoids and the regulation of memory consolidation. Psychoneuroendocrinology 25: 213-238.
56. Roozendaal B, Hui GK, Hui IR, Berlau DJ, McGaugh JL, Weinberger NM. 2006a. Basolateral amygdala noradrenergic activity mediates corticosterone-induced enhancement of auditory fear conditioning. Neurobiol Learn Mem 86:249-255.
57. Roozendaal B, Okuda S, de Quervain DJ, McGaugh JL. 2006b. Glucocorticoids interact with emotion-induced noradrenergic activation in influencing different memory functions. Neuroscience 138:901-910.
58. Roozendaal B, Okuda S, Van der Zee EA, McGaugh JL. 2006c. Glucocorticoid enhancement of memory requires arousal-induced noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci U S A 103:6741-6746.
59. Russ H, Staust K, Martel F, Gliese M, Schomig E. 1996. The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia. Eur J Neurosci 8:1256-1264.
60. Schmitt A, Mossner R, Gossmann A, Fischer IG, Gorboulev V, Murphy DL, Koepsell H, Lesch KP. 2003. Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice. J Neurosci Res 71:701-709.
61. Schomig E, Lazar A, Grundemann D. 2006. Extraneuronal monoamine transporter and organic cation transporters 1 and 2: a review of transport efficiency. Hdbk Exp Pharmacol 175:151-180.
62. Shang T, Uihlein AV, Van Asten J, Kalyanaraman B, Hillard CJ. 2003. 1-Methyl-4-phenylpyridinium accumulates in cerebellar granule neurons via organic cation transporter 3. J Neurochem 85:358-367.
63. Sladek JR Jr, Sladek CD. 1978. Localization of serotonin within tanycytes of the rat median eminence. Cell Tissue Res 186:465-474.
64. Streich S, Bruss M, Bonisch H. 1996. Expression of the extraneuronal monoamine transporter (uptake2) in human glioma cells. Naunyn Schmiedebergs Arch Pharmacol 353:328-333.
65. Stutzmann GE, McEwen BS, Ledoux JE. 1998. Serotonin modulation of sensory inputs to the lateral amygdala: dependency on corticosterone. J Neurosci 18:9529-9538.
66. Summers CH, Larson ET, Ronan PJ, Hofmann PM, Emerson AJ, Renner KJ. 2000. Serotonergic responses to corticosterone and testosterone in the limbic system. Gen Comp Endocrinol 117:151-159.
67. Summers TR, Matter JM, McKay JM, Ronan PJ, Larson ET, Renner KJ, Summers CH. 2003. Rapid glucocorticoid stimulation and GABAergic inhibition of hippocampal serotonergic response: in vivo dialysis in the lizard anolis carolinensis. Horm Behav 43:245-253.
68. Sweet DH, Miller DS, Pritchard JB. 2001. Ventricular choline transport: a role for organic cation transporter 2 expressed in choroid plexus. J Biol Chem 276:41611-41619.
69. Takeda H, Inazu M, Matsumiya T. 2002. Astroglial dopamine transport is mediated by norepinephrine transporter. Naunyn Schmiedebergs Arch Pharmacol 366:620-623.
70. Vialou V, Amphoux A, Zwart R, Giros B, Gautron S. 2004. Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation. J Neurosci 24:2846-2851.
71. Wu X, Kekuda R, Huang W, Fei YJ, Leibach FH, Chen J, Conway SJ, Ganapathy V. 1998. Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 273:32776-32786.
72. Zhou M, Engel K, Wang J. 2007. Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain. Biochem Pharmacol 73:147-154.